Self-testing is recognised for its potential to positively impact HIV detection rates. The convenience and privacy afforded by HIV self-testing can have a role to play in reaching previously undiagnosed and at-risk groups.
By working with HIV charities and frontline health professionals in countries with high HIV infection rates, Atomo has developed integrated HIV self-test solutions to meet the needs of lay users. The tests require only a small drop of blood from the fingertip, and give an accurate result in just 15 minutes.
HIV self-tests designed and manufactured by Atomo are CE marked and available from specialist commercialisation partners in multiple countries worldwide.
The Atomo HIV Self Test is available in Australia directly from Atomo Diagnostics – visit atomohivtest.com for details – and is the first and only HIV self-test to have been approved by the Australian Therapeutic Goods Administration (TGA).